The mechanism underlying tumor promotion involves the mediation of the cell cycle promotion rather than mitosis, as cyclin D1, but not cyclin B1, was decreased in HCT116, SUIT-2 and OE33 cells by the downregulation of SNRPE. The gene discussed is CCNB1; the disease is neoplasm.